Cardioprotective effects of p‐coumaric acid on tachycardia, inflammation, ion pump dysfunction, and electrolyte imbalance in isoproterenol‐induced experimental myocardial infarction

Abstract

AbstractCardiovascular diseases cause a large number of deaths throughout the world. No research was conducted earlier on p‐coumaric acid's effect on tachycardia, inflammation, ion pump dysfunction, and electrolyte imbalance. Hence, we appraised the above‐said parameters in isoproterenol‐induced myocardial infarcted rats. This investigation included 24 male albino Wistar rats in 4 groups. Normal control Group 1, p‐coumaric acid (8 mg/kg body weight) alone treated Group 2, Isoproterenol (100 mg/kg body weight) induced myocardial infarcted Group 3, p‐coumaric acid (8 mg/kg body weight) pretreated isoproterenol (100 mg/kg body weight) induced Group 4. After 1 day of the last dose of isoproterenol injection (day 10), rats were killed and blood and heart were taken and inflammatory markers, lipid peroxidation, nonenzymatic antioxidants, ion pumps, and electrolytes were measured. The heart rate, serum cardiac troponin‐T, serum/plasma inflammatory markers, and heart proinflammatory cytokines were raised in isoproterenol‐induced rats. Isoproterenol also enhanced plasma lipid peroxidation, lessened plasma nonenzymatic antioxidants, and altered heart ion pumps and serum and heart electrolytes. In this study, p‐coumaric acid pretreatment orally for 7 days to isoproterenol‐induced myocardial infarcted rats prevented changes in the above‐cited parameters. p‐Coumaric acid's anti‐tachycardial, anti‐inflammatory, anti‐ion pump dysfunction and anti‐electrolyte imbalance properties are the mechanisms for these cardioprotective effects.